Schrödinger – Talk Bio

Schrödinger Halts SGR-2921 Leukaemia Programme After Two Deaths

4 weeks ago talkbio0Tagged CDC7 protein, human, clinical trial halt, drug safety, Inhibitor, leukemia, Leukemia, Myelocytic, Acute, MYELODYSPLASTIC SYNDROME, patient deaths, Schrödinger, SGR-2921

Schrödinger; SGR-2921; leukaemia; acute myeloid leukaemia (AML); myelodysplastic syndromes (MDS); CDC7 inhibitor; clinical trial halt; patient deaths; drug safety

Schrödinger Lays Off 60 Staffers Amid Economic Uncertainty

4 months ago talkbio0Tagged Economic Conditions, Financial cost, layoffs, restructuring, Schrödinger, Transection (procedure)

Schrödinger; layoffs; biotech; workforce reduction; economic conditions; cost cutting; restructuring

Novartis and Schrödinger Forge $150M Drug Discovery Partnership with Billions in Potential Milestones

10 months ago talkbio0Tagged Drug Discovery, multi-target, multiyear collaboration, Novartis, Papillary thyroid carcinoma, Schrödinger

Novartis, Schrödinger, drug discovery pact, $150M upfront payment, multiyear collaboration, multi-target agreement.